Robeco Institutional Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-872,700	Closed	-$2.56M	–	1007
2018 Q1	$2.56M	Hold	872,700	–	–	0.01%	627
2017 Q4	$2.39M	Sell	872,700 -147,100	-14%	-$452K	0.01%	597
2017 Q3	$3.46M	Hold	1,019,800	–	–	0.02%	499
2017 Q2	$2.52M	Hold	1,019,800	–	–	0.02%	550
2017 Q1	$2.32M	Sell	1,019,800 -1,946,802	-66%	-$4.31M	0.02%	555
2016 Q4	$6.29M	Sell	2,966,602 -34,104	-1%	-$95.2K	0.05%	341
2016 Q3	$10.1M	Sell	3,000,706 -6,970	-0.2%	-$22.1K	0.07%	268
2016 Q2	$9.45M	Sell	3,007,676 -45,576	-1%	-$152K	0.07%	253
2016 Q1	$10.2M	Sell	3,053,252 -5,594	-0.2%	-$17.4K	0.08%	237
2015 Q4	$10.8M	Buy	3,058,846 +600,426	+24%	+$2.51M	0.09%	227
2015 Q3	$12.4M	Buy	2,458,420 +14,286	+0.6%	+$81.9K	0.09%	243
2015 Q2	$15.7M	Sell	2,444,134 -158,597	-6%	-$1.06M	0.12%	217
2015 Q1	$18.3M	Sell	2,602,731 -16,354	-0.6%	-$118K	0.14%	204
2014 Q4	$20.2M	Buy	2,619,085 +1,056,071	+68%	+$8.36M	0.14%	187
2014 Q3	$11.7M	Buy	1,563,014 +607,726	+64%	+$5.64M	0.08%	236
2014 Q2	$9.25M	Buy	955,288 +2,225	+0.2%	+$19.8K	0.07%	256
2014 Q1	$7.92M	Buy	953,063 +621,005	+187%	+$5.32M	0.06%	263
2013 Q4	$2.8M	Buy	+332,058	New	+$2.8M	0.02%	331